Nearly a year after announcing its direct-to-consumer fitness tracker AmpStrip -- and after raising more than $500,000 on Indiegogo for it -- Fitlinxx has announced that it will not be developing AmpStrip as a fitness tracker, but rather as a medical device. The company will refund all of its nearly 4,000 backers on request. Engadget first reported the news.
The news came in an update to the...